Skip to main content
Timothy Smith, MD, Neurosurgery, Boston, MA

TimothyRichardSmithMD

Neurosurgery Boston, MA

Associate Professor, Neurosurgery, Harvard Medical School

Dr. Smith is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Smith's full profile

Already have an account?

  • Office

    60 Fenwood Ave.
    Department Of Neurosurgery
    Boston, MA 02115
    Phone+1 617-525-3060
    Fax+1 312-695-0225

Education & Training

  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityResidency, Neurological Surgery, 2008 - 2014
  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityInternship, Transitional Year, 2007 - 2008
  • David Geffen School of Medicine at UCLA
    David Geffen School of Medicine at UCLAClass of 2007

Certifications & Licensure

  • ME State Medical License
    ME State Medical License Current
  • CA State Medical License
    CA State Medical License 2024 - 2026
  • RI State Medical License
    RI State Medical License 2023 - 2026
  • CT State Medical License
    CT State Medical License 2023 - 2025
  • MA State Medical License
    MA State Medical License 2014 - 2025
  • NH State Medical License
    NH State Medical License 2019 - 2025
  • VT State Medical License
    VT State Medical License 2023 - 2024
  • American Board of Neurological Surgery Neurological Surgery
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • First-Line Treatment with Checkpoint Inhibitors Associated with Improved Overall Survival for Patients with Melanoma Brain Metastases
    First-Line Treatment with Checkpoint Inhibitors Associated with Improved Overall Survival for Patients with Melanoma Brain MetastasesJuly 12th, 2018
  • RevBio Receives FDA Approval to Conduct a First-in-Human Clinical Trial for Its Regenerative Bone Adhesive for Cranial Flap Fixation
    RevBio Receives FDA Approval to Conduct a First-in-Human Clinical Trial for Its Regenerative Bone Adhesive for Cranial Flap FixationDecember 14th, 2023
  • FDA Greenlights RevBio’s Innovative Bone Glue Trial for Cranial Surgery
    FDA Greenlights RevBio’s Innovative Bone Glue Trial for Cranial SurgeryDecember 23rd, 2023

Professional Memberships